201 KAR 2:220REG

A proposed version of this document exists.

201 KAR 2:220.Collaborative care agreements.

RELATES TO:

KRS 315.010(4), 315.121, 315.040(4), 315.191(1)(a)

STATUTORY AUTHORITY:

KRS 315.191(1)(a)

NECESSITY, FUNCTION, AND CONFORMITY:

KRS 315.191(1)(a) authorizes the Board of Pharmacy to promulgate administrative regulations to regulate and control matters relating to pharmacists, pharmacist interns, pharmacy technicians, pharmacies, wholesale distributors, and manufacturers. This administrative regulation establishes minimum requirements for the development and maintenance of collaborative care agreements between pharmacist and practitioner.

Section 1.

A collaborative care agreement shall:

(1)

Be in writing;

(2)

Be signed and dated by:

(a)

Each practitioner; and

(b)

Each pharmacist who is a party to the agreement;

(3)

Provide the method for referral of patients to be managed under the agreement; and

(4)

State the method for termination of the agreement.

Section 2.

The following information relating to a patient managed under the collaborative care agreement shall be maintained by the pharmacist:

(1)

Name;

(2)

Address and phone number;

(3)

Emergency notification contact;

(4)

Date of birth, weight, height, and gender;

(5)

Medical history, including:

(a)

Known diseases;

(b)

Known allergies;

(c)

Reactions and conditions relating to:

1.

Prescription medications; and

2.

Nonprescription medications;

(d)

Current prescription regimen; and

(e)

Current nonprescription regimen;

(6)

Lab tests ordered, including results of lab tests;

(7)

Assessment of patient outcomes;

(8)

Notes relating to the care and course of therapy of the patient; and

(9)

Documentation of patient consent to receive care under the collaborative care agreement.

Section 3.

Documentation relating to the care and course of therapy of the patient pursuant to the agreement shall be documented in the patient's record maintained by the pharmacist, provided to the collaborating practitioner, and be readily available to other healthcare professionals providing care to the patient.

Section 4.

A collaborative care agreement shall comply with KRS 315.010(4) and contain the following information:

(1)

Protocol, criteria, standing orders, or other method by which services are authorized;

(2)

The method established for the assessment of patient outcomes, if appropriate; and

(3)

Lab tests that may be ordered.

Section 5.

A collaborative care agreement and information and records required by the provisions of this administrative regulation shall be maintained:

(1)

At the pharmacist's practice site; and

(2)

For at least five (5) years after termination.

HISTORY: (23 Ky.R. 3125; Am. 3807; 4109; eff. 6-16-1997; 34 Ky.R. 2421; eff. 8-1-2008; 42 Ky.R.458; 1548; 1710; eff. 12-16-2015; Certified to be amended, filing deadline 3-9-2024.)

201 KAR 2:220.Collaborative care agreements.

RELATES TO:

KRS 315.010(4), 315.121, 315.040(4), 315.191(1)(a)

STATUTORY AUTHORITY:

KRS 315.191(1)(a)

NECESSITY, FUNCTION, AND CONFORMITY:

Section 1.

A collaborative care agreement shall:

(1)

Be in writing;

(2)

Be signed and dated by:

(a)

Each practitioner; and

(b)

Each pharmacist who is a party to the agreement;

(3)

Provide the method for referral of patients to be managed under the agreement; and

(4)

State the method for termination of the agreement.

Section 2.

The following information relating to a patient managed under the collaborative care agreement shall be maintained by the pharmacist:

(1)

Name;

(2)

Address and phone number;

(3)

Emergency notification contact;

(4)

Date of birth, weight, height, and gender;

(5)

Medical history, including:

(a)

Known diseases;

(b)

Known allergies;

(c)

Reactions and conditions relating to:

1.

Prescription medications; and

2.

Nonprescription medications;

(d)

Current prescription regimen; and

(e)

Current nonprescription regimen;

(6)

Lab tests ordered, including results of lab tests;

(7)

Assessment of patient outcomes;

(8)

Notes relating to the care and course of therapy of the patient; and

(9)

Documentation of patient consent to receive care under the collaborative care agreement.

Section 3.

Section 4.

A collaborative care agreement shall comply with KRS 315.010(4) and contain the following information:

(1)

Protocol, criteria, standing orders, or other method by which services are authorized;

(2)

The method established for the assessment of patient outcomes, if appropriate; and

(3)

Lab tests that may be ordered.

Section 5.

A collaborative care agreement and information and records required by the provisions of this administrative regulation shall be maintained:

(1)

At the pharmacist's practice site; and

(2)

For at least five (5) years after termination.

HISTORY: (23 Ky.R. 3125; Am. 3807; 4109; eff. 6-16-1997; 34 Ky.R. 2421; eff. 8-1-2008; 42 Ky.R.458; 1548; 1710; eff. 12-16-2015; Certified to be amended, filing deadline 3-9-2024.)

Page Generated: 5/12/2023, 4:33:50 PM

Title 201 | Chapter 002 | Regulation 220

201 KAR 2:220.Collaborative care agreements.

RELATES TO:

STATUTORY AUTHORITY:

NECESSITY, FUNCTION, AND CONFORMITY:

Section 1.

(1)

(2)

(a)

(b)

(3)

(4)

Section 2.

(1)

(2)

(3)

(4)

(5)

(a)

(b)

(c)

1.

2.

(d)

(e)

(6)

(7)

(8)

(9)

Section 3.

Section 4.

(1)

(2)

(3)

Section 5.

(1)

(2)

201 KAR 2:220.Collaborative care agreements.

RELATES TO:

STATUTORY AUTHORITY:

NECESSITY, FUNCTION, AND CONFORMITY:

Section 1.

(1)

(2)

(a)

(b)

(3)

(4)

Section 2.

(1)

(2)

(3)

(4)

(5)

(a)

(b)

(c)

1.

2.

(d)

(e)

(6)

(7)

(8)

(9)

Section 3.

Section 4.

(1)

(2)

(3)

Section 5.

(1)

(2)